NOTCH4 and breast carcinoma: Harrison and coworkers isolated BCSCs from breast cancer cell lines and primary breast cancer samples by sorting cells resistant to anoikis or cells containing markers of ESA+/CD44+/CD24low, and they found that Notch4 is specifically overexpressed in these BCSCs [44].